Haven Chemical Health Systems Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Haven Chemical Health Systems's estimated annual revenue is currently $3.2M per year.(i)
  • Haven Chemical Health Systems's estimated revenue per employee is $80,000

Employee Data

  • Haven Chemical Health Systems has 40 Employees.(i)
  • Haven Chemical Health Systems grew their employee count by -9% last year.

Haven Chemical Health Systems's People

NameTitleEmail/Phone
1
Accounting ManagerReveal Email/Phone
2
LADCReveal Email/Phone
3
License alcohol and drug counselorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.8M353%N/AN/A
#2
$3M38-12%N/AN/A
#3
$3.4M4330%N/AN/A
#4
$31M2826%N/AN/A
#5
$2.7M34-6%N/AN/A
#6
$48.8M3902%N/AN/A
#7
$6.3M708%N/AN/A
#8
$4.7M5218%N/AN/A
#9
$6.2M698%N/AN/A
#10
$13.9M1396%N/AN/A
Add Company

What Is Haven Chemical Health Systems?

Haven Chemical Health Systems opened its doors in 2000 with one outpatient facility, The Haven in Woodbury. Not long after, two additional facilities were opened: The Haven in Shakopee, an outpatient facility, and Margaret’s House, a ten-bed residential facility for women in Mendota Heights. These were followed shortly by the opening of The Haven in Waconia, as well as The Haven in Cloquet. In 2004, Rebecca’s Residence in Scandia was opened, which is also a ten-bed women’s residential facility. Our first men's residential facility, Paul's Place, opened in 2008 in Farmington with six beds. We currently offer Adult (18+) Intensive Outpatient Treatment in Woodbury, Shakopee, Waconia, and Cloquet. We have also added Case Management for those clients who need this service at our Woodbury, Waconia, and Shakopee locations.

keywords:N/A

N/A

Total Funding

40

Number of Employees

$3.2M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.9M415%N/A
#2
$10M413%N/A
#3
$8.5M420%N/A
#4
$9.3M4316%N/A
#5
$7.6M43-4%N/A